Last reviewed · How we verify
NCT06256913: 2022PI172
Machine Learning Approach Based on Echocardiographic Data to Improve Prediction of Cardiovascular Events in Hypertrophic Cardiomyopathy
trial in Hypertrophic Cardiomyopathy in 870 participants. Status unknown.
6 May 2024
Quick facts
| Lead sponsor | Pr. Nicolas GIRERD |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 870 |
| Start date | 6 May 2023 |
| Primary completion | 6 May 2024 |
| Estimated completion | 6 May 2024 |
| Sites | 2 locations across France |
Conditions studied
- Hypertrophic Cardiomyopathy — all drugs for Hypertrophic Cardiomyopathy →
Sponsor
Pr. Nicolas GIRERD — full company profile →
Who can join
18 and older, any sex, with Hypertrophic Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypertrophic cardiomyopathy is a pathology with a highly variable course, ranging from patients who are asymptomatic throughout their lives to those who experience sudden death and/or terminal heart failure. The main objective is to develop and validate an algorithm (constructed through supervised learning) using cardiac imaging data to predict the risk of cardiovascular events in sarcomeric hypertrophic cardiomyopathy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06256913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertrophic Cardiomyopathy
Currently open trials in the same condition.
- NCT07361289 — A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa · recruiting
- NCT06490250 — Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients · NA · recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT06549608 — A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada · active not recruiting
- NCT05939700 — Mavacamten Pregnancy Surveillance Program · recruiting
Other Pr. Nicolas GIRERD trials
Trials by the same sponsor.
- NCT06509854 — PAthwAy of Dyspneic patIent in Emergency in France · not yet recruiting
- NCT06235008 — PAthwAy of Dyspneic patIent in Emergency in the North-east Region (North-East PArADIsE) · not yet recruiting
- NCT05772091 — Prognostic Value of Echocardiographic Parameters Based on Machine Learning Approach · unknown
- NCT05818280 — Relationship Between 24-hour Blood Pressure Variability and FRagility in the Elderly Patient · completed
- NCT05089162 — CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06256913 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pr. Nicolas GIRERD
- Last refreshed: 13 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06256913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing